Opportunity Information: Apply for CDC RFA GH10 1005
Apply for CDC RFA GH10 1005
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Developing a Regional Public Health Surveillance and Laboratory Network for Central America with the Secretara General del Sistema de la Integracin Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamrica (COMISCA)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Mar 4, 2010 and posted on Mar 4, 2010.
- Applicants must submit their applications by May 4, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,000,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Assistance will be provided only to the Secretara General del Sistema de la Integracin Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamrica (COMISCA). No other applications are solicited. SG SICA/COMISCA is the most appropriate and qualified agency to conduct the activities specified under this cooperative agreement because 1. SG SICA/COMISCA is the entity that represents all of the Ministers of Health of Central America. It is both a political and a technical entity. SG SICA/COMISCA is uniquely positioned, in terms of legal authority and support from all Ministries of Health in Central America, to collaborate with CDC Central America and Panama (CAP) to enhance sustainable public health surveillance and laboratory networks in the region. 2. As such, the SG SICA/COMISCA can easily work with all of the Ministries of Health of the Central America region in a way that no other entity can. The Ministers of Health of eight countries have agreed to support the development of a shared information platform which will be managed by the SG SICA/COMISCA. No other entity in the region has this capacity. 3. The Ministers have authorized SG SICA/COMISCA to coordinate a regional response to the influenza pandemic no other entity has such authorization. 4. SG SICA/COMISCA has experience executing a large public health project financed by the World Bank that was focused on training and laboratory strengthening related to HIV AIDS. The World Bank is satisfied with the execution of this project and is discussing financing a second phase to continue their work. 5. As the entity that represents the Central American Ministers of Health, SG SICA/COMISCA is the only organization in the region that has the authority to develop plans for regional public health networks including surveillance and laboratory. 6. SG SICA/COMISCA is the only entity that can pass funds to the Central American Ministries of Health and can contract personnel for the Ministries of Health. 7. SG SICA/COMISCA has the political authority necessary to call for regional meetings, and since it has been doing this for years it also has the administrative capacity needed. SG SICA/COMISCA is the only organization able to function in this capacity as they are actually mandated by the multiple Ministries of Health to do so. 8. SG SICA/COMISCA has a fiscal management system in place that is unique within the region in that their financial records (consisting of funds from all eight Ministries of Health from each of the eight countries) for all of their activities are audited by an independent third party organization. 9. SG SICA/COMISCA has demonstrated previous success both programmatically and establishing public health policy by brokering an agreement (the Integration Treaty for Central America) between all eight Central American countries to have a uniform list of 36 different medications that can be used to treat several fundamental health concerns within the region. No other entity in Central America has the capability to issue multi lateral agreements of this nature that reflects an agreement between not only Ministers of Health, but also the Presidents of each of the countries in Central America other public health entities are only able to provide recommendations for action. 10. SG SICA/COMISCA has established, and coordinates, multiple subject matter expert groups (e.g., medical services, surveillance, HIV/AIDS, etc.) that are considered to be an authoritative voice by all eight countries in Central America. 11. SG SICA/COMISCA has established a five year plan for public health in Central America that has been formulated and agreed upon by all eight Ministers of Health in the region the activities in this plan directly coincide with CDC CAP s public health initiatives. 12. Because of their unique position, both politically and programmatically, in the region, the US Secretary for Health has signed a Letter of Intent with the Minister
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The CDC funding opportunity CDC-RFA-GH10-1005, titled "Developing a Regional Public Health Surveillance and Laboratory Network for Central America with the Secretaria General del Sistema de la Integracion Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamerica (COMISCA)," was a discretionary cooperative agreement designed to strengthen regional disease surveillance and laboratory capacity across Central America. It was posted on March 4, 2010, and closed on May 4, 2010, with an estimated total funding amount of $10,000,000. The program was framed around several Healthy People 2010 focus areas, including health communication; HIV; immunization and infectious diseases; public health infrastructure; respiratory diseases; and sexually transmitted diseases. It also directly supported HHS/CDC performance goals tied to protecting Americans from infectious diseases through global health promotion, health protection, and health diplomacy, reflecting the idea that improving outbreak detection and response capacity abroad helps reduce cross-border and global health threats.
This award was structured as a cooperative agreement, meaning CDC anticipated substantial involvement and collaboration rather than a hands-off grant relationship. In practical terms, the intent was to work with regional health leadership to build or enhance shared systems that allow countries to detect, confirm, track, and respond to infectious disease events more quickly and consistently. The opportunity emphasizes a regional approach, focusing not only on strengthening individual country capacities but also on improving coordination, information-sharing, and standardization across multiple ministries of health. A key element referenced in the eligibility rationale is the development of a shared information platform to be managed regionally, which suggests the program envisioned interoperable surveillance reporting and communication channels that could support routine monitoring as well as emergency response, such as during influenza pandemics.
Eligibility was restricted to a single applicant: SG SICA/COMISCA. No other applications were solicited, and no cost sharing or matching requirement applied. The announcement justifies this limitation by laying out why SG SICA/COMISCA was viewed as uniquely capable of leading and sustaining a region-wide public health surveillance and laboratory network. SG SICA/COMISCA represents the Ministers of Health of Central America and functions as both a political and technical body, giving it regional legitimacy and the authority needed to coordinate cross-country action in a way that other organizations cannot. The text highlights that the Ministers of Health from eight countries agreed to support a shared information platform under SG SICA/COMISCA management, and that SG SICA/COMISCA had been authorized to coordinate a regional response to the influenza pandemic, demonstrating an explicit mandate for regional emergency coordination.
The eligibility justification also points to operational and fiduciary capacities that matter for a large, multi-country public health investment. SG SICA/COMISCA is described as the only entity able to pass funds to the Central American ministries of health and contract personnel for them, which is crucial for implementing a network that depends on consistent staffing, training, and technical work across national systems. The organization is also portrayed as having a strong administrative track record: it can convene regional meetings, manage complex projects, and maintain a fiscal management system whose financial records are audited by an independent third party. The announcement further cites prior experience executing a large World Bank-financed public health project focused on HIV/AIDS training and laboratory strengthening, with satisfactory performance and potential follow-on financing, as evidence of capacity to deliver results at scale.
Beyond implementation capacity, the notice underscores SG SICA/COMISCA's policy-making influence and ability to broker and formalize regional agreements. It references a successful multi-country agreement under the Central American integration framework that established a uniform list of 36 medications for priority health concerns, illustrating the organization can translate technical consensus into regionally adopted policy backed not only by health ministers but also by heads of state. This matters for surveillance and laboratory networks because long-term effectiveness typically depends on shared standards (case definitions, reporting rules, lab protocols, quality systems), sustained commitments, and cross-border protocols for specimen referral, data exchange, and coordinated response actions. The announcement also notes that SG SICA/COMISCA coordinates multiple subject matter expert groups and has an agreed-upon five-year public health plan aligned with CDC Central America and Panama initiatives, signaling that the proposed work was meant to fit within an existing regional strategy rather than operate as a stand-alone project.
In summary, this opportunity funded one regional partner to lead the development and strengthening of coordinated public health surveillance and laboratory networking across Central America, with CDC engaged as an active collaborator. The core rationale was that SG SICA/COMISCA, as the formal representative body of Central American health ministers with demonstrated convening power, policy authority, administrative reach, and audited financial systems, was uniquely positioned to implement a shared regional platform and coordinate both routine and emergency infectious disease surveillance and response. For applicants or stakeholders looking back at this notice, the main takeaway is that it was a single-source, region-building investment aimed at improving detection and response to infectious threats in ways that benefit both the region and broader global health security goals.
Frequently Asked Questions (FAQs)
What is CDC-RFA-GH10-1005?
CDC-RFA-GH10-1005 is a CDC funding opportunity titled "Developing a Regional Public Health Surveillance and Laboratory Network for Central America with the Secretaria General del Sistema de la Integracion Centroamericana (SG SICA) / Consejo de Ministros de Salud de Centroamerica (COMISCA)." It was designed to strengthen regional disease surveillance and laboratory capacity across Central America through a coordinated, multi-country approach.
What type of funding mechanism was this opportunity?
This opportunity was a discretionary cooperative agreement. That structure indicates CDC expected substantial involvement and collaboration with the recipient, rather than a hands-off relationship typical of some grants.
When was the opportunity posted and when did it close?
The opportunity was posted on March 4, 2010, and it closed on May 4, 2010.
How much funding was available?
The estimated total funding amount was $10,000,000.
Who was eligible to apply?
Eligibility was restricted to a single applicant: SG SICA/COMISCA. No other applications were solicited.
Was cost sharing or matching required?
No. The opportunity specified that no cost sharing or matching requirement applied.
Why was eligibility limited to SG SICA/COMISCA?
The announcement justified the single-applicant limitation by describing SG SICA/COMISCA as uniquely positioned to lead and sustain a region-wide public health surveillance and laboratory network. It emphasized the organization’s regional legitimacy, political and technical authority, ability to coordinate cross-country action, and administrative and fiduciary capacity for a large, multi-country public health investment.
What is SG SICA/COMISCA in the context of this opportunity?
SG SICA/COMISCA represents the Ministers of Health of Central America and functions as both a political and technical body. In this funding notice, it is described as the only entity with the authority and legitimacy to coordinate regional action across multiple ministries of health.
What was the main goal of the program?
The main goal was to develop and strengthen a coordinated regional public health surveillance and laboratory network across Central America so that countries could detect, confirm, track, and respond to infectious disease events more quickly and consistently.
What does a "regional approach" mean in this program?
A regional approach, as described in the notice, means strengthening not only individual country capacities but also cross-border coordination, information-sharing, and standardization across multiple ministries of health.
What kinds of activities or capabilities was the program meant to strengthen?
Based on the notice description, the program emphasized strengthening shared systems that support outbreak detection and response, improving coordination among countries, increasing consistency of surveillance and laboratory practices, and enabling faster and more standardized tracking and response to infectious disease events.
Did the opportunity include a shared information platform?
Yes. A key element referenced in the eligibility rationale was the development of a shared information platform managed regionally under SG SICA/COMISCA, suggesting interoperable surveillance reporting and communication channels for routine monitoring and emergency response.
How did the opportunity relate to emergency response (such as influenza pandemics)?
The opportunity referenced emergency response needs in the context of a regional platform and coordination, including mention that SG SICA/COMISCA had been authorized to coordinate a regional response to the influenza pandemic. The notice suggests the network could support both routine surveillance and emergency response situations.
What role did CDC expect to play under this cooperative agreement?
Because it was a cooperative agreement, CDC anticipated substantial involvement and collaboration with the recipient. The intent was to work with regional health leadership to build or enhance shared regional systems for surveillance and laboratory networking.
Why did the notice emphasize SG SICA/COMISCA's ability to pass funds and contract personnel?
The eligibility justification states SG SICA/COMISCA was the only entity able to pass funds to Central American ministries of health and contract personnel for them, which was portrayed as crucial for implementing a network requiring consistent staffing, training, and technical work across multiple national systems.
What administrative or financial management strengths were cited for SG SICA/COMISCA?
The notice described SG SICA/COMISCA as having the ability to convene regional meetings, manage complex projects, and maintain a fiscal management system with financial records audited by an independent third party.
What past experience was referenced as evidence of SG SICA/COMISCA's capacity?
The announcement cited prior experience executing a large World Bank-financed public health project focused on HIV/AIDS training and laboratory strengthening, describing performance as satisfactory and noting potential follow-on financing.
Did the notice describe SG SICA/COMISCA's ability to create or formalize regional agreements?
Yes. The notice highlighted policy-making influence and the ability to broker and formalize regional agreements, including an example of a multi-country agreement establishing a uniform list of 36 medications for priority health concerns under the Central American integration framework.
Why does policy influence matter for a surveillance and laboratory network?
As framed in the notice, long-term effectiveness depends on shared standards and sustained commitments across countries, such as common case definitions, reporting rules, laboratory protocols, quality systems, and cross-border protocols for specimen referral, data exchange, and coordinated response actions.
Which Healthy People 2010 focus areas were associated with this opportunity?
The notice framed the program around several Healthy People 2010 focus areas: health communication; HIV; immunization and infectious diseases; public health infrastructure; respiratory diseases; and sexually transmitted diseases.
How did this opportunity connect to HHS/CDC performance goals?
The notice stated that the opportunity directly supported HHS/CDC performance goals tied to protecting Americans from infectious diseases through global health promotion, health protection, and health diplomacy, based on the idea that improving outbreak detection and response capacity abroad reduces cross-border and global health threats.
Was the program intended to fit within an existing regional strategy?
Yes. The notice indicated SG SICA/COMISCA had an agreed-upon five-year public health plan aligned with CDC Central America and Panama initiatives, suggesting the work was meant to fit within an existing regional strategy rather than operate as a stand-alone project.
Is this opportunity still open?
No. The funding opportunity closed on May 4, 2010.
What is the main takeaway for someone reviewing this notice today?
The notice describes a single-source, region-building investment intended to strengthen coordinated surveillance and laboratory networking across Central America, with CDC actively collaborating. The rationale emphasized SG SICA/COMISCA’s unique regional authority, convening power, administrative reach, and audited financial systems to manage and sustain a shared regional approach.
Browse more opportunities from the same category: Health
Next opportunity: Notice of Intent Single Source Award Museum Collection Support
Previous opportunity: ROSES 2010 Modeling, Analysis, and Prediction
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH10 1005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH10 1005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Hepatitis C Treatment Expansion Initiative Demonstration Sites Apply for HRSA 10 090 Funding Number: HRSA 10 090 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Poison Center Support and Enhancement Grant Program, Incentive Grants Apply for HRSA 10 051 Funding Number: HRSA 10 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improving HIV Prevention Initiatives in Communities in the Republic of Zambia under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10109 Funding Number: CDC RFA PS10 10109 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| ARRA CHARN Central Data Management Coordination Center Apply for HRSA 10 206 Funding Number: HRSA 10 206 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| EMSC Targeted Issue Grants Apply for HRSA 10 062 Funding Number: HRSA 10 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: $300,000 |
| Global Partnerships with Non Governmental Organizations (NGO s) Apply for CDC FOA GH10 1003 Funding Number: CDC FOA GH10 1003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| AETC National Multicultural Center Apply for HRSA 10 149 Funding Number: HRSA 10 149 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIAID Advanced Technology SBIR (NIAID AT SBIR R43/R44) Apply for PA 10 123 Funding Number: PA 10 123 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| NIAID Advanced Technology STTR (NIAID AT STTR R41/R42) Apply for PA 10 124 Funding Number: PA 10 124 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NHLBI Research Centers at Minority Serving Institutions (P30) Apply for RFA HL 11 019 Funding Number: RFA HL 11 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Laboratory Technical Implementation Assistance for Public Health Cooperative Agreement Program Apply for CDC RFA HK10 1001ARRA10 Funding Number: CDC RFA HK10 1001ARRA10 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Basic/Core Area Health Education Centers Apply for HRSA 10 116 Funding Number: HRSA 10 116 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Model State Supported Area Health Education Centers Apply for HRSA 10 117 Funding Number: HRSA 10 117 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening HIV Strategic Information Activities in the Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1073 Funding Number: CDC RFA PS10 1073 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Scaling up Integrated, Effective and Sustainable Services for the Prevention of Mother to Child HIV Transmission (PMTCT) in the Republic of Uganda under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1021 Funding Number: CDC RFA PS10 1021 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,500,000 |
| Strengthening HIV and Co infection Prevention Activities in Central Asian Republics of Kazakhstan, Kyrgyz Republic, Tajikistan, Turkmenistan, and Uzbekistan Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1074 Funding Number: CDC RFA PS10 1074 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening TB/HIV activities in the Central Asian Republics of Kazakhstan, Kyrgyz, Tajikistan, Turkmenistan, and Uzbekistan under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1089 Funding Number: CDC RFA PS10 1089 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| FY10 Promote, Support and Build Capacity in the Medical Reserve Corps Apply for SG MRC 10 001 Funding Number: SG MRC 10 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $5,650,000 |
| Strengthening HIV/AIDS Prevention for Most at Risk Populations in Namibia Apply for 674 10 0027 Funding Number: 674 10 0027 Agency: South Africa USAID Pretoria Category: Health Funding Amount: $5,400,000 |
| HIV prevention activities in target communities in Zambia Apply for 611 2010 09AMENDMENT01 Funding Number: 611 2010 09AMENDMENT01 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $4,400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH10 1005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.